Sotirchos VS, et al. Colorectal cancer liver metastases: biopsy of the ablation zone and margins can be used to predict oncologic outcome. Radiology. 2016;280(3):949–59.
Shady W, et al. Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control. J Vasc Interv Radiol. 2018;29(2):268-275.e1.
Cornelis FH, et al. Immediate postablation (18)F-FDG injection and corresponding SUV are surrogate biomarkers of local tumor progression after thermal ablation of colorectal carcinoma liver metastases. J Nucl Med. 2018;59(9):1360–5.
Article CAS PubMed PubMed Central Google Scholar
Kurilova I, et al. Factors associated with local tumor control and complications after thermal ablation of colorectal cancer liver metastases: a 15-year retrospective cohort study. Clin Colorectal Cancer. 2021;20(2):e82–95.
Vasiniotis Kamarinos N, et al. Biopsy and margins optimize outcomes after thermal ablation of colorectal liver metastases. Cancers (Basel). 2022;14(3).
Faber RA, et al. Three-dimensional quantitative margin assessment in patients with colorectal liver metastases treated with percutaneous thermal ablation using semi-automatic rigid MRI/CECT-CECT co-registration. Eur J Radiol. 2022;156: 110552.
Lin YM, et al. Ablative margins of colorectal liver metastases using deformable ct image registration and autosegmentation. Radiology. 2023;307(2): e221373.
Laimer G, et al. Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases. Eur Radiol. 2021;31(9):6489–99.
Article PubMed PubMed Central Google Scholar
Benson AB et al. Colon cancer, Version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(3):329–59.
Cervantes A, et al. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(1):10–32.
Article CAS PubMed Google Scholar
Ryan ER, et al. Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness. Radiology. 2013;268(1):288–95.
Article PubMed PubMed Central Google Scholar
Zirakchian Zadeh M et al. Real-time split-dose PET/CT-guided ablation improves colorectal liver metastasis detection and ablation zone margin assessments without the need for repeated contrast injection. Cancers (Basel). 2022;14(24).
Laimer G, et al. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation. Eur Radiol. 2020;30(5):2463–72.
Article PubMed PubMed Central Google Scholar
Kishore SA, Drabkin MJ, Sofocleous CT. Fluorodeoxyglucose-PET for ablation treatment planning, intraprocedural monitoring, and response. PET Clinics. 2019;14(4):427–36.
Casadaban LC, et al. Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study. Eur J Nucl Med Mol Imaging. 2021;48(9):2914–24.
Shyn PB, et al. PET/CT-guided percutaneous liver mass biopsies and ablations: targeting accuracy of a single 20 s breath-hold PET acquisition. Clin Radiol. 2014;69(4):410–5.
Article CAS PubMed Google Scholar
Kaye EA, et al. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression. Eur Radiol. 2019;29(5):2698–705.
VasiniotisKamarinos N, et al. 3D margin assessment predicts local tumor progression after ablation of colorectal cancer liver metastases. Int J Hyperthermia. 2022;39(1):880–7.
Im HJ, et al. Current methods to define metabolic tumor volume in positron emission tomography: which one is better? Nucl Med Mol Imaging. 2018;52(1):5–15.
Cheebsumon P, et al. Effects of image characteristics on performance of tumor delineation methods: a test-retest assessment. J Nucl Med. 2011;52(10):1550–8.
Article CAS PubMed Google Scholar
Moon SH, Hyun SH, Choi JY. Prognostic significance of volume-based PET parameters in cancer patients. Korean J Radiol. 2013;14(1):1–12.
ZirakchianZadeh M, et al. Comparison of (18)F-sodium fluoride uptake in the whole bone, pelvis, and femoral neck of multiple myeloma patients before and after high-dose therapy and conventional-dose chemotherapy. Eur J Nucl Med Mol Imaging. 2020;47(12):2846–55.
Zadeh MZ, et al. Evolving roles of fluorodeoxyglucose and sodium fluoride in assessment of multiple myeloma patients: Introducing a novel method of PET quantification to overcome shortcomings of the existing approaches. PET Clin. 2019;14(3):341–52.
ZirakchianZadeh M, et al. Prognostic significance of conventional and volumetric PET parameters with and without partial volume correction in the assessment of head and neck squamous cell carcinoma. Nucl Med Commun. 2022;43(7):800–6.
ZirakchianZadeh M, et al. A review of different methods used for quantification and assessment of FDG-PET/CT in multiple myeloma. Nucl Med Commun. 2022;43(4):378–91.
Ahmed M, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273(1):241–60.
Ryan ER, et al. PET/CT-guided interventions: personnel radiation dose. Cardiovasc Intervent Radiol. 2013;36(4):1063–7.
Taghvaei R, et al. Pre-treatment partial-volume-corrected TLG is the best predictor of overall survival in patients with relapsing/refractory non-hodgkin lymphoma following radioimmunotherapy. Am J Nucl Med Mol Imaging. 2018;8(6):407–14.
CAS PubMed PubMed Central Google Scholar
Zadeh MZ, et al. Prognostic significance of (18)F-sodium fluoride in newly diagnosed multiple myeloma patients. Am J Nucl Med Mol Imaging. 2020;10(4):151–60.
CAS PubMed PubMed Central Google Scholar
Seraj SM, et al. The evolving role of PET-based novel quantitative techniques in the interventional radiology procedures of the liver. PET Clin. 2019;14(4):419–25.
Carter JV, et al. ROC-ing along: evaluation and interpretation of receiver operating characteristic curves. Surgery. 2016;159(6):1638–45.
Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–63.
Article PubMed PubMed Central Google Scholar
Gönen M, Panageas KS, Larson SM. Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient. Radiology. 2001;221(3):763–7.
Suzuki O, et al. Defining PET standardized uptake value threshold for tumor delineation with metastatic lymph nodes in head and neck cancer. Jpn J Clin Oncol. 2012;42(6):491–7.
Wilson JM, Partridge M, Hawkins M. The application of functional imaging techniques to personalise chemoradiotherapy in upper gastrointestinal malignancies. Clin Oncol (R Coll Radiol). 2014;26(9):581–96.
Article CAS PubMed Google Scholar
Erdi YE, et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer. 1997;80(12 Suppl):2505–9.
Article CAS PubMed Google Scholar
Lin Y, et al. Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer. Anticancer Res. 2012;32(11):5087–91.
Graves EE, Quon A, Loo BW Jr. RT_Image: an open-source tool for investigating PET in radiation oncology. Technol Cancer Res Treat. 2007;6(2):111–21.
Werner-Wasik M, et al. What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom. Int J Radiat Oncol Biol Phys. 2012;82(3):1164–71.
Geets X, et al. A gradient-based method for segmenting FDG-PET images: methodology and validation. Eur J Nucl Med Mol Imaging. 2007;34(9):1427–38.
Sridhar P, et al. FDG PET metabolic tumor volume segmentation and pathologic volume of primary human solid tumors. AJR Am J Roentgenol. 2014;202(5):1114–9.
Nelson A, et al. PET tumor segmentation: Validation of a gradient-based method using a NSCLC PET phantom. J Nucl Med. 2009;50(supplement 2):1659–1659.
Takeda K, et al. Clinical utility of texture analysis of 18F-FDG PET/CT in patients with Stage I lung cancer treated with stereotactic body radiotherapy. J Radiat Res. 2017;58(6):862–9.
留言 (0)